Where Biogen Stands With Analysts

Loading...
Loading...

Within the last quarter, Biogen BIIB has observed the following analyst ratings:

Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago
Bullish 2 0 0 0
Somewhat Bullish 1 1 1 0
Indifferent 4 0 1 0
Somewhat Bearish 0 0 0 0
Bearish 0 0 0 0

In the last 3 months, 11 analysts have offered 12-month price targets for Biogen. The company has an average price target of $382.27 with a high of $500.00 and a low of $245.00.

This current average represents a 31.28% increase from the previous average price target of $291.18.

Analyst Ratings: What Are They?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Analysts also give out recommendations like "buy", "sell", "hold", or similar verbage for each stock based on their overall evaluations of the corres ponding company. A "buy" indicates that an analyst is optimistic about a stock's short-term or mid-term growth, recommending traders to purchase the stock. Contrastingly, a "sell" means that an analyst believes the stock will trend downwards in that same time frame. A "hold" suggests that investors should not buy more of or sell any of the specified stock due to that analyst's prediction of stagnation.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...